Graves Ophthalmopathy
📧 Sign up to get email alerts when something new happens for Graves Ophthalmopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy [Phase 1, Phase 2]
A Phase 1 and Phase 2 trial investigating azithromycin as an immunomodulatory therapy for Graves' ophthalmopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction [Phase 4]
Phase 4 clinical trial evaluating Botox for thyroid-related upper eyelid retraction in Graves' ophthalmopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-09Clinical Trial Update: Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment [NA]
A clinical trial evaluating bromocriptine and pentoxifylline for Graves' ophthalmopathy has been terminated.